| Name | Sterling #28 |
|---|---|
| Organization Name | Astrup Drug Inc |
| Location | 137w Main St, Spring Grove, Minnesota 55974 |
| Type | Pharmacy |
| Phone | (507) 498-5509 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
› Verified 6 days ago
| NPI Number | 1306920491 |
| Organization Name | RUSHFORD DRUG COMPANY |
| Doing Business As | WITT'S PHARMACY - SPRING GROVE |
| Type | Pharmacy |
| Address | 137 W Main St, Spring Grove, MN 55974 |
| Phone Number | 507-498-5509 |
News Archive
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
› Verified 6 days ago
| NPI Number | 1316206709 |
| Organization Name | ASTRUP DRUG INC |
| Doing Business As | STERLING #28 |
| Type | Community/Retail Pharmacy |
| Address | 137 W Main St, Spring Grove, MN 55974 |
| Phone Number | 507-498-5509 |
News Archive
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
› Verified 6 days ago
| NPI Number | 1962019364 |
| Organization Name | ASTRUP DRUG INC |
| Type | Long Term Care Pharmacy |
| Address | 137 W Main St, Spring Grove, MN 55974 |
| Phone Number | 507-498-5509 |
News Archive
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
› Verified 6 days ago
News Archive
Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
› Verified 6 days ago
Sterling #28 Type: Pharmacy Location: 137w Main St, Spring Grove, Minnesota 55974 Phone: (507) 498-5509 |